GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 12, 2014, inter alia, to consider amongst other things, approval of unaudited financial results for the quarter April - June 2014 (Q2) and half-year January - June 2014.<br/><br/>The trading window for dealing in securities of GlaxoSmithKline Pharmaceuticals Limited will remain closed until August 14, 2014 for all the designated employees, directors etc. pursuant to the applicable SEBI regulations.
|